Antibody drug lowers risk of death in elderly coronavirus patients: Study

- Biocon Ltd received regulatory approval in India for itolizumab for use in coronavirus infected patients
- Researchers, which developed itolizumab, said timely use of the drug in combination with standard therapy helped reduce inflammation and prevented COVID-19 from worsening